Diabetes Tools' TriabetesClinic Nominated for 2016 Global Mobile Awards

Diabetes ToolsDiabetes Tools has been nominated for Best Mobile Innovation for Health in the GSMA's 2016 Global Mobile Awards for its TriabetesClinic online decision support service that puts medical apps at the heart of diabetes treatment for insulin-dependent children, both in hospital and remotely at home.

"TriabetesClinic for Children combines mobile apps for patient self-care and on-ward mobility with online tools to simplify and digitally rearrange the care around each child with diabetes," said Diabetes Tools' Chief Executive Officer Anders Weilandt. "To be chosen by the Glomo Awards judging committee shows that the digital health sector is gaining ground. However, digital health still has a long way to go. This nomination energizes our team's already considerable persistence and dedication to go the distance."

"Congratulations to all of the nominees for the 2016 Glomo Awards," said Michael O’Hara, Chief Marketing Officer, GSMA. "With more than 930 entries this year - a new record - the competition is greater than ever, reflecting the tremendous diversity and pace of innovation across the mobile world. We are particularly excited to be celebrating the 21st year of the awards with a dynamic new format that will recognise and honour achievement throughout Mobile World Congress."

The Glomo Awards highlight achievements and innovations across the mobile industry and include more than 40 awards in eight categories. The 2016 winners will be announced during Mobile World Congress, the world's largest mobile industry exhibition and conference, in Barcelona, Spain (22 - 25 February). For more information, visit http://www.globalmobileawards.com/nominees2016/.

Triabetes and TriabetesClinic are registered trademarks of Diabetes Tools Sweden AB.

About Diabetes Tools
Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better.

Diabetes Tools was named "MedTech Company of the Year 2014" by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...